Search Results

Site Search

newborn-screen-follow-up-elevated-arginine.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 04/2025 Newborn screen result (NBS): Elevated arginine Perform plasma ammonia Order all of the following: ■ AAQP / Amino Acids, Quantitative, Plasma ■ OAU /...

newborn-screen-follow-up-for-metachromatic-leukodystrophy.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 07/2025 Newborn Screen Follow-up For Metachromatic Leukodystrophy STOP False-positive newborn screen Newborn screen result: Elevated sulfatides and/or...

autoimmune-paraneoplastic-myelopathy-evaluation-algorithm-serum.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2024 Autoimmune/Paraneoplastic Myelopathy Evaluation Algorithm-Serum ■ TRIM46 antibody by CBA ■ TRIM46 antibody by IF titer assay ■ Amphiphysin...

MCL Hereditary Dyslipidemia Patient Information MC1235295

MCL Hereditary Dyslipidemia Patient Information Complete print Reset Form Hereditary Dyslipidemia Patient Information Instructions Accurate interpretation reporting genetic results contingent

https://news.mayocliniclabs.com/mc2775-782/

N N E C T I N G Pharma and biotech TABLE OF CONTENTS What makes a good testing partner? Case study 1 Gastrointestinal study collects and tests patient specimens at......

Mayo Clinic Laboratory and Pathology Research Roundup: January 9 - Insights

inflammatory disease, on treatment with daily subcutaneous injections of 600 mg of recombinant interleukin-1 receptor antagonist (IL-1Ra) protein, anakinra, since the age of 28, who presented with golf-ball size...

ISO15189 Accredited Certificate NEW 2024 PDF Ver.psmd

The organization named above is granted this accreditation in accordance with the recognized International Standard ISO 15189:2012, Medical Laboratories – Requirements for quality and competence. This accreditation demonstrates competence...

October 2023 - Pulmonary Pathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Pulmonary Pathology.

Mayo Clinic Laboratory and Pathology Research Roundup: January 23 - Insights

administered in recurrent GBM patients either at the resection cavity (Group A), or, intratumorally on day 1, followed by a second dose administered in the resection cavity after tumor resection on day 5 (Group...

autoimmune-paraneoplastic-movement-disorder-evaluation-algorithm-serum.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2024 Autoimmune/Paraneoplastic Movement Disorder Evaluation Algorithm – Serum ■ GFAP alpha subunit antibody by CBA ■ GFAP alpha subunit antibody by...

newborn-screen-elevated-c0-c16-c18.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 08/20/23 Newborn screen results: ■ Elevated or normal free carnitine (C0) ■ Elevated C0/C16+C18 ratio Perform: Plasma ammonia, blood gas, glucose,...

MCL Coagulation Test Request Form T753 MC076704A

MCL Coagulation Test Request Form T753 Complete print Reset Form Coagulation Test Request Client Information required Client Patient Information required Patient ID Medical Record

MCL Combined Immunodeficiency Severe Combined Immunodeficiency and BCellAntibody Deficiency Patient Information MC1235309

MCL Combined Immunodeficiency Severe Combined Immunodeficiency BCellAntibody Deficiency Patient Information Complete print Reset Form Combined Immunodeficiency Severe Combined Immunodeficiency Cell Antibody Deficiency Patient Information...

vitamin_b12_deficiency_evaluation.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 03/2022 Vitamin B12 Deficiency Evaluation <150 ng/L>400 ng/L 150-400 ng/L ≤0.4 nmol/mL >0.4 nmol/mL INDETERMINATE ACASM / Pernicious Anemia Cascade,...

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) calculator - Insights

For guidance on when to use the calculator, please see the following algorithm: Acquired Neuropathy Diagnostic Algorithm.

New tests launched in May - Insights

In May 2022, Mayo Clinic Laboratories announced multiple new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Pathways Case Studies: October 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for October include the following sub-specialties Breast Pathology, Gynecological...

Units of Measurement - Mayo Clinic Laboratories

Units of Measure A list of common units used in the reporting of our assays has been defined. Refer to the table for these units as well as the recommended report abbreviations. Last updated: June 6, 2025...

MCL - Blood Spot Collection Instructions (Spanish) - Brochure - MC4091-67SP

MCL - Blood Spot Collection Instructions (Spanish) - Brochure

October 2023 - Clinical Microbiology - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.

Mayo Clinic Laboratories Critical Values / Critical Results List

Mayo Clinic Laboratories Critical Values / Critical Results List DEFINITION A Critical Value / Critical Result is defined as: A value/result that represents a pathophysiological state at such variance with normal (expected values) as...

Units of Measurement - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

MCL Genetics Whole Genome Sequencing Flyer MC2775658

MCL Genetics Genome Sequencing Flyer GENOME SEQUENCING COMPREHENSIVE GENETIC TESTING ADVANCE DIAGNOSIS Clinic Laboratories genome sequencing WGS test utilizes generation

Pleural Mesothelioma - Insights

In this month's "Hot Topic," Anja Roden, M.D., a thoracic pathologist at Mayo Clinic, gives an update on the 2021 World Health Organization (WHO) classification and ancillary testing of pleural mesothelioma.

Whole exome sequencing for hereditary disorders - Insights

Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...

New Tests Launched in February - Insights

In February 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests - Mayo Clinic Laboratories

Share Print Web: mayocliniclabs.com...

Whole genome sequencing - Insights

Check out Mayo Clinic Laboratories’ whole genome testing, a next-generation sequencing assay that interrogates nearly every base pair of an individual’s DNA, including the mitochondrial genome.

https://www.mayocliniclabs.com/-/media/mediax/customer-service/mayoaccess/ma-workstation-setup-guide.pdf?sc_lang=en&hash=80F7F54389FE5FFAE754B5711FC4EF75

MayoACCESS® Workstation Setup Guide Page 2 4/28/25 MayoACCESS Workstation Setup Guide TABLE OF CONTENTS Introduction...

July 2022 - Laboratory Genetics and Genomics and Molecular Pathology - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialties are Laboratory Genetics and Genomics and Molecular Pathology.

Ethanol - Insights

Learn more about how direct ethanol biomarker testing at Mayo Clinic Laboratories provides heightened sensitivity and specificity to accurately assess alcohol use and alcohol use disorder.

Large Scale Study: Outcomes for Long QT Syndrome Patients Treated at Specialty Center Are Better - Insights

Sudden cardiac death and episodes of fainting and seizures from long QT syndrome are significantly lower than previously thought when patients are diagnosed and treated at a specialty center dedicated to the treatment of genetic heart...

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

CPT codes and LOINC update: December 2024 - Insights

This will be the last CPT Codes and LOINC update. Read why.

IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights

In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.

Precision mental and behavioral health therapeutics - Insights

Our Precision Mental and Behavioral Health Therapeutics initiative leverages cutting-edge diagnostic solutions to optimize medication management for psychiatric and neurologic patients.

Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus] - Insights

Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can...

Pathways Case Studies: April 2021 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for April include the following sub-specialties: Genitourinary Pathology,...

Emergency/Overdose - Mayo Clinic Laboratories

Emergency/Overdose This test is intended to manage an apparent overdose, intoxicated patient, or determine if a specific set of symptoms might be due to the presence of drugs. This test is designed...

Applying the Staffing-to-Workload Methodology: Same-Day Testing Staffing Model - Insights

Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses how to apply the staffing-to-workload methodology to accommodate same-day testing requirements.

MCL Neurogenetics Delivering Precision Results Through ExpertBacked Advanced Evaluations MC2775732

MCL Neurogenetics Delivering Precision Results ExpertBacked Advanced Evaluations NEUROGENETICS DELIVERING PRECISION RESULTS EXPERT BACKED ADVANCED EVALUATIONS neurogenetic testing unparalleled scope includes molecular

critical-values-semi-urgent-results-list.pdf

PURPOSE DEFINITON Test Report Name Age Critical Low Critical High Units Activated Partial Thromboplastin Time, Plasma Any – ≥ 150 sec Fibrinogen Any ≤ 60 – mg/dL 0 – 7 weeks ≤ 6.0 ≥ 24.0 g/dL > 7 weeks ≤ 6.0 ≥ 20.0 g/dL INR (International...

VEXAS syndrome - Insights

Find out more about UBA1Q, a quantitative droplet digital polymerase chain reaction (ddPCR) assay that targets seven possible mutations that can occur in the UBA1 gene and help identify VEXAS syndrome.